Skip to main content
. 2014 Jun 20;7(4):447–455. doi: 10.1016/j.tranon.2014.05.004

Figure 3.

Figure 3

Survival analysis based on overall patient response. (a–d) Survival analysis according to tumor response criteria [EASL, mRECIST, qEASL (cm3), and qEASL (%)]. All patients were non-responders using WHO, RECIST, and vRECIST criteria; thus, no survival data could be calculated.